Anaplastic Lymphoma Kinase (ALK) Inhibitor
Date: Jan-2019 | Id: MACRC-0821 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ...